Pharmacovigilance Business Model - A DETAILED STUDY OF THE PHARMACEUTICALS FROM THE MANUFACTURER TO THE CUSTOMER

Yash Halvawala

Diplomová práce

Abstract:

Like in any other businesses manufacturing and providing the goods, eatables to the market, requires certifications, legalizing procedures etc. there is the field of Pharmaceuticals, which also need to fulfil numerous guidelines before making sale of their product in the market. In, recent years there has been emergence of this new field in the business of pharmacy known as Pharmacovigilance. The pharmacovigilance is that sector of business which is the bridge that connects the pharmaceutical company with the pharmacies and chemist shops. The European Medicines Agency (EMA) coordinates the European Union (EU) pharmacovigilance system and operates services and processes to support pharmacovigilance in the EU. As quoted by EMA, Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. This business model contains in total 6 organs like, Quality Assurance (QA), Pharmacovigilance (PV), Regulatory Affairs (RA), Distribution, Human Resources (HR) & Finance.

Keywords

European Medicines Agency (EMA), Medicines & Healthcare products Regulatory Agency (MHRA), Co-ordination Group for Mutual Recognition and Decentralized Procedures – Human (CMDh), Heads of Medicines Agencies (HMA), Quality Assurance (QA), Pharmacovigilance (PV), Regulatory Affairs (RA)

Jazyk práce: angličtina

Datum vytvoření / odevzdání či podání práce: 25. 11. 2023

Obhajoba závěrečné práce

• Obhajoba proběhla 6. 2. 2024
• Vedoucí: Wilem Heijman
• Oponent: Ludka Fyles, externi

Česká zemědělská univerzita v Praze

Provozně ekonomická fakulta

Magisterský studijní program:
Business Administration